LC-MS Analysis of Highly Sialylated Glycans Using MS Compatible Mixed Mode Chromatographic Separation
Posters | 2021 | Waters | ASMSInstrumentation
The sialylation level of N-glycans significantly influences the pharmacokinetics and biological activity of glycoprotein therapeutics. Accurate analysis of highly sialylated structures is challenging using conventional hydrophilic interaction chromatography (HILIC) coupled with fluorescence detection and mass spectrometry (FLR-MS).
This work evaluates a mixed-mode reversed-phase/anionic exchange (RP/AX) LC-FLR-MS method on the Waters BioAccord System for improved separation and characterization of fluorescently labeled, highly sialylated N-glycans released from recombinant erythropoietin (rEPO).
Mixed-mode RP/AX separation achieved approximately 20 % narrower peak widths and superior resolution of isomeric sialylated glycans compared to HILIC. Charge-driven retention differences allowed grouping by the number of sialic acids, enabling distinct elution of glycan species such as tetra-antennary FA4S3 and FA4G4S4. Fragment ion spectra provided complementary compositional confirmation, including sialic acid count and monosaccharide sequence.
The optimized method improves resolving power for complex and highly sialylated glycan mixtures and streamlines compositional assignments in biopharmaceutical characterization workflows. It supports robust glycan profiling for quality control and structure–function studies.
Future developments may integrate higher-resolution MS detection, automated data processing, and application to a broader range of glycoproteins. The approach is well-suited for advanced biopharmaceutical QC and glycoengineering research.
The mixed-mode RP/AX LC-FLR-MS method on BioAccord with an ACQUITY Premier Glycan C18 AX column provides enhanced separation and characterization of highly sialylated N-glycans, offering improved peak capacity, charge-based selectivity, and reliable compositional analysis.
Birdsall R., Yu Y. Q. LC-MS Analysis of Highly Sialylated Glycans Using MS Compatible Mixed Mode Chromatographic Separation. Waters Corporation, Milford MA, 2021.
HPLC, LC/TOF, LC/HRMS, LC/MS
IndustriesProteomics
ManufacturerWaters
Summary
Význam tématu
The sialylation level of N-glycans significantly influences the pharmacokinetics and biological activity of glycoprotein therapeutics. Accurate analysis of highly sialylated structures is challenging using conventional hydrophilic interaction chromatography (HILIC) coupled with fluorescence detection and mass spectrometry (FLR-MS).
Cíle a přehled studie / článku
This work evaluates a mixed-mode reversed-phase/anionic exchange (RP/AX) LC-FLR-MS method on the Waters BioAccord System for improved separation and characterization of fluorescently labeled, highly sialylated N-glycans released from recombinant erythropoietin (rEPO).
Použitá metodika a instrumentace
- Sample: rEPO from European Pharmacopeia and commercial supplier, labeled by GlycoWorks RFMS Kit.
- Chromatography: Mixed-mode separation on ACQUITY Premier Glycan BEH C18 AX column (1.7 μm, 2.1×150 mm); comparison to ACQUITY Premier Glycan Amide HILIC column.
- Instrumentation: Waters BioAccord System with ACQUITY Premier LC, FLR detector (Ex 265 nm, Em 425 nm) and integrated bench-top MS.
- Mobile phases: 100 mM ammonium formate/formic acid in water/ACN for RP/AX; 50 mM ammonium formate and acetonitrile for HILIC.
- Data analysis: waters_connect with UNIFI software.
Hlavní výsledky a diskuse
Mixed-mode RP/AX separation achieved approximately 20 % narrower peak widths and superior resolution of isomeric sialylated glycans compared to HILIC. Charge-driven retention differences allowed grouping by the number of sialic acids, enabling distinct elution of glycan species such as tetra-antennary FA4S3 and FA4G4S4. Fragment ion spectra provided complementary compositional confirmation, including sialic acid count and monosaccharide sequence.
Přínosy a praktické využití metody
The optimized method improves resolving power for complex and highly sialylated glycan mixtures and streamlines compositional assignments in biopharmaceutical characterization workflows. It supports robust glycan profiling for quality control and structure–function studies.
Budoucí trendy a možnosti využití
Future developments may integrate higher-resolution MS detection, automated data processing, and application to a broader range of glycoproteins. The approach is well-suited for advanced biopharmaceutical QC and glycoengineering research.
Závěr
The mixed-mode RP/AX LC-FLR-MS method on BioAccord with an ACQUITY Premier Glycan C18 AX column provides enhanced separation and characterization of highly sialylated N-glycans, offering improved peak capacity, charge-based selectivity, and reliable compositional analysis.
Reference
Birdsall R., Yu Y. Q. LC-MS Analysis of Highly Sialylated Glycans Using MS Compatible Mixed Mode Chromatographic Separation. Waters Corporation, Milford MA, 2021.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Released Glycan Analysis of Erythropoietin Using the ACQUITY Premier Glycan BEH C 18 AX Column and BioAccord System with ACQUITY Premier
2021|Waters|Applications
Application Note Released Glycan Analysis of Erythropoietin Using the ACQUITY Premier Glycan BEH C 18 AX Column and BioAccord System with ACQUITY Premier Ximo Zhang, Robert E. Birdsall, Ying Qing Yu Waters Corporation Abstract The abundance and structure of highly…
Key words
glycan, glycansialylated, sialylatedbioaccord, bioaccordglycans, glycanspremier, premierflr, flracquity, acquityhilic, hilichighly, highlymixed, mixedcharge, chargeerythropoietin, erythropoietinbased, basedbranched, branchedassignments
Improving Chromatographic Separations Of Biopharmaceuticals With MaxPeak High Performance Surfaces (HPS) Technology
2023|Waters|Brochures and specifications
Improving Chromatographic Separations Of Biopharmaceuticals With MaxPeak High Performance Surfaces (HPS) Technology Analytical Solutions Using MaxPeak High Performance Surfaces (HPS) Technology for Biopharmaceutical Therapeutics Biopharmaceutical therapeutics have consistently been the fastest growing segment within the pharmaceutical space and require advances…
Key words
premier, premieracquity, acquityglycan, glycanmaxpeak, maxpeaknucleotide, nucleotideculture, culturehps, hpspeptide, peptideintact, intactsystem, systembioaccord, bioaccordcolumn, columnread, readprotein, proteinglycans
Increased Resolving Power for Acidic Glycans with an MS-Compatible Anion Exchange Reversed Phase Separation
2020|Waters|Applications
Application Note Increased Resolving Power for Acidic Glycans with an MS-Compatible Anion Exchange Reversed Phase Separation Xiaoxiao Liu, Matthew A. Lauber Waters Corporation Abstract Glycosylation are often assigned as critical quality attributes in certain biotherapeutics because they can affect stability,…
Key words
glycans, glycansglycan, glycanacidic, acidicpmol, pmolresolution, resolutionisomeric, isomericrfms, rfmsderivatized, derivatizedacquity, acquityspecies, speciesrapifluor, rapifluorlabeled, labeledanion, anioncommercially, commerciallyimproved
Improving Released N-glycan Analysis in Biotherapeutic Development Using the ACQUITY Premier Solution with MaxPeak High Performance Surfaces (HPS) Technology
2021|Waters|Applications
Application Note Improving Released N-glycan Analysis in Biotherapeutic Development Using the ACQUITY Premier Solution with MaxPeak High Performance Surfaces (HPS) Technology Ximo Zhang, Jacob Kellett, Robert E. Birdsall, Ying Qing Yu Waters Corporation Abstract Characterization and monitoring of glycosylation are…
Key words
glycan, glycanglycans, glycansacquity, acquitybioaccord, bioaccordpremier, premierreleased, releasedunifi, unifiamide, amidebeh, behflr, flrhps, hpsmaxpeak, maxpeaklysosomal, lysosomalsystem, systemmetal